Ripple Therapeutics Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 41

Employees

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $595K

  • Investors
  • 9

Ripple Therapeutics General Information

Description

Developer of a drug delivery system designed for sustained drug delivery without the use of polymers or excipients. The company focuses on ophthalmic therapeutics and specializes in discovering and engineering drugs into controlled-release materials without the use of polymers or excipients, and its prodrug materials are readily manufactured into implantable forms like cylinders and microspheres, providing patients with better outcomes, easier management of care for physicians, and lower costs for payors.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • MaRS Center, South Tower
  • 101 College Street, Suite 300
  • Toronto, Ontario M5G 1L7
  • Canada
+1 (416)
Primary Industry
Drug Delivery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • MaRS Center, South Tower
  • 101 College Street, Suite 300
  • Toronto, Ontario M5G 1L7
  • Canada
+1 (416)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Ripple Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Grant 27-Apr-2022 $595K Completed Clinical Trials - Phase 1
5. Early Stage VC (Series A) 08-Mar-2022 Completed Clinical Trials - Phase 1
4. Accelerator/Incubator 01-May-2020 Completed Startup
3. Seed Round 02-Jan-2020 Completed Clinical Trials - Phase 1
2. Accelerator/Incubator Completed Clinical Trials - Phase 1
1. University Spin-Out 01-Jan-2019 Completed Startup
To view Ripple Therapeutics’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Ripple Therapeutics Patents

Ripple Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20260193289-A1 Processable statins and use for the same Pending 19-Dec-2024
WO-2026132908-A1 Processable statins and use for the same Pending 19-Dec-2024
WO-2026132909-A2 Processable statins and use for the same Pending 19-Dec-2024
WO-2026132909-A3 Steroid linked statins as implants for ophthalmic use Pending 19-Dec-2024
US-20260007686-A1 Compositions and methods for improving vision Pending 12-Jul-2022 A61K31/573
To view Ripple Therapeutics’s complete patent history, request access »

Ripple Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ripple Therapeutics Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
National Research Council Canada Government
Théa Open Innovation Venture Capital Minority
Ontario Bioscience Innovation Organization Not-For-Profit Venture Capital
BDC Capital Growth/Expansion Minority
Covington Capital Corporation Venture Capital Minority
You’re viewing 5 of 9 investors. Get the full list »

Ripple Therapeutics FAQs

  • When was Ripple Therapeutics founded?

    Ripple Therapeutics was founded in 2019.

  • Where is Ripple Therapeutics headquartered?

    Ripple Therapeutics is headquartered in Toronto, Canada.

  • What is the size of Ripple Therapeutics?

    Ripple Therapeutics has 41 total employees.

  • What industry is Ripple Therapeutics in?

    Ripple Therapeutics’s primary industry is Drug Delivery.

  • Is Ripple Therapeutics a private or public company?

    Ripple Therapeutics is a Private company.

  • What is Ripple Therapeutics’s current revenue?

    The current revenue for Ripple Therapeutics is .

  • How much funding has Ripple Therapeutics raised over time?

    Ripple Therapeutics has raised $23.4M.

  • Who are Ripple Therapeutics’s investors?

    National Research Council Canada, Théa Open Innovation, Ontario Bioscience Innovation Organization, BDC Capital, and Covington Capital Corporation are 5 of 9 investors who have invested in Ripple Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process